Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability.
Young Nam KwonBoram KimJun-Soon KimHeejung MoKyomin ChoiSeong-Il OhJee-Eun KimTai-Seung NamEun Hee SohnSung Hyuk HeoSang Beom KimKey-Chung ParkSung Sang YoonJeeyoung OhSeol-Hee BaekByung-Jo KimKyung Seok ParkJung-Joon SungJae Ho JungSeong-Joon KimSung-Hye ParkPatrick J WatersSung-Min KimPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
This study provides Class II evidence that the presence of CSF MOG-IgG can improve the diagnosis of MOGAD in the absence of an MS phenotype, and intrathecal synthesis of MOG-IgG was associated with increased disability.